期刊文献+

坎地沙坦酯片对正常高值血压患者的疗效观察 被引量:1

Investigation of curative effeet of the Candesartan cilexetil tablets to the patients with high normal blood pressure
下载PDF
导出
摘要 目的:观察坎地沙坦酯片对伴有头晕、头痛的正常高值血压患者的影响。方法:选择伴有头晕、头痛的正常高值血压患者86例,随机分为对照组和治疗组。对照组非药物治疗,治疗组非药物治疗加坎地沙坦酯片。结果:①临床疗效:总有效率对照组32.6%,治疗组88.4%,治疗组明显优于对照组(P<0.01)。②血压变化:两组治疗后与同组治疗前比较,对照组收缩压(SBP)和舒张压(DBP)有所降低,但差异无统计学意义(均P>0.05);而治疗组SBP和DBP明显降低(均P<0.01)。两组治疗后相比较,治疗组SBP和DBP明显降低(均P<0.01)。结论:坎地沙坦酯片治疗伴有头晕、头痛症状的正常高值血压者有效、安全。 Objective To investigate the curative effect of Candesartan eilexetil tablets in the patients who have dizziness ,headache and high normal blood pressure. Method Eighty -six patients with dizziness, headache and high normal blood pressure were divided into two groups;one was control group,the other was treatment group. The control group received non -drug therapy, the treatment group received non -drug therapy added Candesartan cilexetil tablets. Results (1) Clinical curative effect:the total effective rate of the treatment group (88.4%) was obviously higher than that of the control group (32. 6% ) (P 〈 0. 01 ). (2) The changes of blood pressure:after treatment, the SBP (systolic blood pressure,SBP) and DBP (Diastolic blood pressure,DBP) decreased in control group and had no statistically signifi- cant (P 〉 0. 05) but decreased notably in treatment group (P 〈 0. O1 ). Then compared the two groups after therapy, the SBP and DBP of treatment group decreased more than control group ( P 〈 0. 01 ). Conclusion The compound treatment of Candesartan Cilexetil Tablets has utility and safety effect for the patients with dizziness, headache and high normal blood pressure.
出处 《吉林医学》 CAS 2012年第25期5393-5394,共2页 Jilin Medical Journal
基金 国家自然科学基金资助项目(项目编号:30760240)
关键词 正常高值血压 头晕、头痛 坎地沙坦酯片 High normal blood pressure Dizziness, Headache Candesartan cilexetil tablets
  • 相关文献

参考文献10

  • 1Chobanian AV,Bakris GL, Black HR,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure:the JNC 7 re- port [J]. JAMA,2003 ,289(19) :2560.
  • 2卫生部心血管病防治研究中心.中国高血压防治指南.高血压杂志,2005,:15-15.
  • 3王薇,赵冬,刘静,孙佳艺,吴桂贤,曾哲淳,刘军,秦兰萍,吴兆苏.中国35~64岁人群血压水平与10年心血管病发病危险的前瞻性研究[J].中华内科杂志,2004,43(10):730-734. 被引量:147
  • 4郭艳英,王坤,赵蕾,何秉贤.新疆博尔塔拉地区多民族血压正常高值人群中伴随心血管病危险因素的分析[J].中华流行病学杂志,2010,31(3):264-268. 被引量:6
  • 5娄培安,陈培培,余加席,张雷,张宁,张盼.徐州市居民正常高值血压危险因素分析[J].中华全科医师杂志,2011,10(1):21-26. 被引量:5
  • 6Greenlund K J, Croft JB, Mensah GA. Prevalence of heart disease and stroke risk factors in persons with prehypertension in the United States, 1999 - 2000 [ J ]. Arch Intern Med, 2004, 164 (19) :2113.
  • 7王进,刘艳萍,杨海英,尹林,陈丽丽.济南铁路职工正常高值血压发生率的变化趋势及相关因素分析[J].东南大学学报(医学版),2012,31(1):56-59. 被引量:6
  • 8Vasari RS,Beiser A,Seshadri S,et al. Residual lifetime risk for developing hypertension in middle - aged women and men : The Framingham Heart Study [ J ]. JAMA ,2002 ,287 (8) : 1003.
  • 9Mochizuki S, Dahlo f B, Shimizu M, et al. Yalsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study) : a randomised, open - label, blinded endpoint morbidity - mortality study [ J ] . Lancet, 2007, 369 (9571) :1431.
  • 10Bartfay WJ,Lehotay DC,Sher GD,et el. Erythropoiesis: Comparison of Cytotoxie Aldehyde Generation in Beta - Thalasse- mia Patients Chelated with Deferoxamine or Defefiprone (L1) Versus NO Chelation [ J ]. Hematology, 1999,4 ( 1 ) : 67.

二级参考文献30

共引文献173

同被引文献13

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部